Código QR (código de barras bidimensional)

Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study

ObjectiveHormone receptor (HR)-low/HER2-negative breast cancers (BCs) are more likely to be basal-like BCs, with similar molecular features and gene expression profiles to HR-negative (estrogen receptor <1% or negative and progesterone receptor <1% or negative) BCs. Recently, with the clinical...

Fuld beskrivelse

Na minha lista:
Principais autores: Jing Peng, Yue Hong, Qitong Chen, Feng Xu, Danhua Zhang, Jia Yao, Qiongyan Zou, Liqin Yuan, Lun Li, Qian Long, Liqiu Liao, Mingwen Liu, Xuan Liu, Shouman Wang, Wenjun Yi
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2024-03-01
Serier:Frontiers in Endocrinology
Fag:
breast cancer
estrogen receptor
progesterone receptor
triple-negative breast cancer
HR-low/HER2-negative breast cancer
neoadjuvant chemotherapy
Online adgang:https://www.frontiersin.org/articles/10.3389/fendo.2024.1347762/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker